StockData
Guided Therapeutics Inc logo

Guided Therapeutics Inc (GTHP) stock

GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 4/30
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026Market cap $15.45MP/E –Yield –

Guided Therapeutics statistics

41 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
32.3%
3.32%
Shares Change (QoQ)
0.03%
0.20%
Float
57M
37M
Shares Held by Insiders
40.7%
10.5%

MarginsIndustry

Gross Margin
75.8%
55.9%
Operating Margin
-303.8%
-5.12%
Pretax Margin
-471.5%
-2.32%
Profit Margin
-471.5%
-9.29%
EBITDA Margin
-303.8%
-2.52%

Returns on capitalIndustry

Return on Assets (ROA)
-287.1%
-12.3%

Financial positionIndustry

Current Ratio
0.09
2.49
Quick Ratio
0.00
1.53
Interest Coverage
-3.29
-1.63

GrowthIndustry

Revenue Growth (YoY)
450.8%
9.42%
Revenue Growth (3Y CAGR)
289.3%
7.08%
Revenue Growth (5Y CAGR)
49.7%
11.8%

EfficiencyIndustry

Asset Turnover
0.61
0.59
Inventory Turnover
0.29
2.20
Revenue Per Employee
$216.67K
$331.99K
Profits Per Employee
-$1.02M
-$46.47K
Employee Count
3
193

Income statement (TTM)Industry

Revenue
$650.00K
$108.17M
Gross Profit
$493.00K
$62.29M
Operating Income
-$1.98M
-$3.72M
Pretax Income
-$3.07M
-$1.83M
Net Income
-$3.07M
-$6.19M
EBITDA
-$1.98M
-$1.98M
EPS (Diluted)
-$0.04
-$0.11

Balance sheetIndustry

Total Debt
$11.00K
$96.00M
Net Cash (Debt)
$1.00K
$3.95M
Net Cash Per Share
$0.00
$0.26
Equity (Book Value)
-$5.76M
$63.80M
Book Value Per Share
-$0.06
$3.26
Tangible Book Value
-$5.76M
$11.61M
Working Capital
-$5.64M
$57.32M

Cash flow (TTM)Industry

Operating Cash Flow
-$1.50M
-$483.87K

Taxes and interestIndustry

Interest Expense
$600.00K
$5.40M
Income Tax
$0
$1.55M

Scores and fair valueIndustry

Piotroski F-Score
4
5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodGTHPS&P 500DifferenceGTHP per yearS&P 500 per year
1 month-30.4%+0.6%−31.1 pts
3 months-42.9%+3.4%−46.2 pts
Year to date-70.4%+13.3%−83.6 pts
1 year-30.5%+16.6%−47.1 pts
3 years+6.7%+86.4%−79.7 pts+2.2%+23.1%
5 years-71.3%+81.9%−153.1 pts-22.1%+12.7%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M GTHP shares were sold short on Oct 30, 2026, up 63.4% from the previous report. At recent volumes it would take 1.0 days to buy them back.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20262,817+63.4%95,1281.0
Oct 15, 20261,724-53.7%20,9621.0
Sep 30, 20263,727-45.4%127,8571.0
Sep 15, 20266,822+55.0%19,7661.0
Aug 31, 20264,400+45.3%25,0851.0
Aug 14, 20263,028+113.8%5,9991.0
Jul 31, 20261,416-1.5%13,7241.0
Jul 15, 20261,437-92.7%29,2931.0
Jun 30, 202619,653-39.5%17,3491.1
Jun 15, 202632,466+9.1%4,0917.9
May 29, 202629,766-29.8%12,8542.3
May 15, 202642,390+14.6%45,8931.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?